463 PHYSICAL INTERACTION BETWEEN INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3 AND ADIPONECTIN: IMPLICATIONS FOR INSULIN SENSITIVITY
| Autor: | P. Cohen, Kuk-Wha Lee, X. H. Yan, L. Cobb, A. Joshi |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
medicine.medical_specialty
Alpha-Collagen biology Adiponectin Growth factor medicine.medical_treatment General Medicine Type 2 diabetes medicine.disease General Biochemistry Genetics and Molecular Biology Insulin-like growth factor-binding protein Insulin resistance Endocrinology In vivo Diabetes mellitus Internal medicine medicine biology.protein hormones hormone substitutes and hormone antagonists |
| Zdroj: | Journal of Investigative Medicine. 54:S159.2-S159 |
| ISSN: | 1708-8267 1081-5589 |
| DOI: | 10.2310/6650.2005.x0004.462 |
| Popis: | Background Obesity is a disease that has reached epidemic proportions; approximately one-third of the adult population in the US is obese. Obesity is a complex multifactorial, chronic disease that is often associated with the prevalence of insulin resistance and type 2 diabetes. Investigation into the mechanism of these diseases may elucidate a method for controlling diabetes. Insulin-like growth factor binding protein 3 (IGFBP-3) is the principal carrier of insulin-like growth factor (IGF) in serum and is found in most tissue types. Besides modulating IGF actions, IGFBP-3 also has IGF-independent roles. Type 1 alpha collagen is one of the recently identified binding partners of IGFBP-3. Furthermore a recent study suggests that chronic infusion of IGFBP-3 into rodents may induce insulin sensitivity. Adiponectin, an adipocytokine, is another factor that may be involved in insulin sensitivity and contains a collagenous domain. Purpose of Study We hypothesized that IGFBP-3 and adiponectin may physically interact. Methods Used In order to study this interaction, in vitro and in vivo studies were conducted using co-immunoprecipitation, radioligand, and dot blot techniques. Summary of Results Results from the in vitro studies using radiolabeled IGFBP-3 and co-immunoprecipitation in serum showed that IGFBP-3 and adiponectin may directly interact. The results from in vivo studies using co-immunoprecipitation of IGFBP-3 and adiponectin in adipocytes showed similar interaction and provide a correlate to the in vitro data. Conclusion We propose that the interface between IGFBP-3 and adiponectin may provide a basis for molecular investigation of obesity in rodent models and humans. This may involve interaction and prevention of adiponectin9s insulin-sensitizing effect. Further study may lead to therapeutics in the treatment of obesity and type 2 diabetes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|